Key result
Kidney transplantation linked to a ~23 mmHg drop in systolic office BP at 12 months.
Why the study?
Hypertension is highly prevalent after kidney transplantation, but office measurements alone fail to characterize 24-hour blood pressure burden or nocturnal profiles.
Observational (n=80)
No
Despite significant improvements in office and ambulatory blood pressure during the first year after kidney transplantation, abnormal circadian profiles and multidrug treatment requirements remain highly prevalent.
Answers are grounded in this paper and cite their sources.
Despite post-transplant BP reduction, non-dipper profiles persist in 81%; leaves open whether ABPM-guided therapy improves outcomes.
Hypertension remains highly prevalent after kidney transplantation, while office measurements alone do not characterize 24-hour blood pressure burden or nocturnal profiles. In this prospective single-center study, 80 adults underwent kidney transplantation in 2022–2023; 47 completed 12-month follow-up and had sufficient serial data. Office blood pressure was assessed before transplantation and at months 3, 6 and 12, and 24-hour ambulatory monitoring on days 7–14 and at months 3 and 6. Associations with age, sex, diabetes, eGFR, PTH, hemoglobin, uric acid, lipids, proteinuria, magnesium supplementation, rejection and corticosteroid exposure were explored. Hypertension remained present in 95.7–97.9%. Office blood pressure decreased from 145.0/89.1 mmHg before transplantation to 123.6/78.1 mmHg at month 3 and 122.1/77.2 mmHg at month 12 (both p < 0.001). Ambulatory blood pressure decreased from 140.8/83.2 mmHg on days 7–14 to 132.0/77.5 mmHg at month 6 (systolic p < 0.001; diastolic p = 0.004). Treatment burden declined from 2.74 to 2.32 agents, but not significantly ( p = 0.139). Non-dipper or reverse-dipper profiles persisted in 81.0% at month 6. Following the early post-transplant period, graft function remained stable between months 3 and 12, with a modest further increase in eGFR ( p = 0.003). PTH decreased markedly ( p < 0.001), correlated inversely with contemporaneous eGFR, and was not an independent determinant of office blood pressure. Blood pressure improved early and remained stable through month 12. Nevertheless, hypertension, multidrug treatment and abnormal circadian profiles remained highly prevalent.
No takes yet. Share an insight, caveat, or question.
Javorkova et al. (2026) conducted an observational in Hypertension after kidney transplantation (n=80). Kidney transplantation vs. Pre-transplantation baseline was evaluated on Systolic office blood pressure at 12 months (p=<0.001). Kidney transplantation was associated with a significant decrease in office blood pressure from 145.0/89.1 mmHg pre-transplantation to 122.1/77.2 mmHg at 12 months.
Synapse has enriched 10 related papers. Consider them for comparative context: